Bank of New York Mellon Corp grew its position in SPDR S&P Biotech (NYSEARCA:XBI) by 1.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 19,274 shares of the exchange traded fund’s stock after buying an additional 197 shares during the period. Bank of New York Mellon Corp’s holdings in SPDR S&P Biotech were worth $1,488,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. National Planning Corp acquired a new stake in shares of SPDR S&P Biotech during the second quarter worth $211,000. Boston Advisors LLC acquired a new stake in shares of SPDR S&P Biotech during the second quarter worth $213,000. Telemus Capital LLC acquired a new stake in shares of SPDR S&P Biotech during the second quarter worth $232,000. FineMark National Bank & Trust grew its stake in shares of SPDR S&P Biotech by 7.4% during the second quarter. FineMark National Bank & Trust now owns 5,210 shares of the exchange traded fund’s stock worth $402,000 after purchasing an additional 360 shares during the period. Finally, Wedbush Securities Inc. acquired a new stake in shares of SPDR S&P Biotech during the second quarter worth $403,000.

ILLEGAL ACTIVITY WARNING: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/10/20/bank-of-new-york-mellon-corp-grows-stake-in-spdr-sp-biotech-xbi.html.

Shares of SPDR S&P Biotech (NYSEARCA XBI) opened at 85.71 on Friday. SPDR S&P Biotech has a 52 week low of $53.15 and a 52 week high of $88.98. The company’s 50 day moving average price is $85.47 and its 200-day moving average price is $76.73.

The business also recently announced a quarterly dividend, which was paid on Monday, September 25th. Investors of record on Monday, September 18th were given a dividend of $0.037 per share. This represents a $0.15 annualized dividend and a yield of 0.17%. The ex-dividend date of this dividend was Friday, September 15th.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Stock Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related stocks with our FREE daily email newsletter.